# ALK to present at the Jefferies Global Healthcare Conference in London

- Published: 2026-11-16
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/alk-to-present-at-the-jefferies-global-healthcare-conference-in-london/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the company’s president & CEO, Peter Halling, is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference in London taking place from 16 - 19 November 2026 on **Wednesday, 18 November 2026, at 10.00 AM GMT / 11.00 AM CET.**

A live webcast of the fireside chat will be accessible through this <a href="https://www.globenewswire.com/Tracker?data=kdiAn0_mfq4CzqA8-SXFtKLIYoEekVzH9x3GOPCXUwMEbq_tOP5GUfNX6LxYJBrQmukOpMSeRhTbHO37pnv7KRPKDnf6WCZkl_Y3k8l19gT7tqrrKlhUQP2BrygZgHy7sR5Jhjfix5G0bi3nw2VGuA==" rel="nofollow">link</a> and available on ALK’s investor site: <a href="https://www.globenewswire.com/Tracker?data=AMY8A-0T0ly-JgyncwMcwzf1aP9codfObX0Fvh39klGEVrqUh-X1N4aukszH1y9sMtE9mTfQlP0EO_mH7brzkO9A34D1hRsCjd7GStxUfWg=" rel="nofollow">Investors | ALK</a>, where a recording of the webcast will also be archived after the event.

Representatives of the company will be available for meetings at the conference.

**ALK-Abelló A/S**

**For further information, please contact:**

*Investor Relations*: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

*Media*: Maiken Riise Andersen, tel. +45 5054 1434

***About ALK***  
*ALK is a global specialty pharmaceutical company focused on allergy. ALK's activities cover the entire value chain of developing, sourcing, producing, and marketing a diversified portfolio of products for diagnosing and treating respiratory allergies and severe allergic reactions (anaphylaxis) in both children and adults.  Headquartered in Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen (Nasdaq: ALK B). Visit us at* <a href="https://www.globenewswire.com/Tracker?data=gfC3yjJIhAsxJvPRRjrqpy6wPd3tzyD7T1D8UqraAecUSY3O-qq9L-z_f--wJW9hc7QxSPB0VOhAzvcTGr4OnWc9ifQwasDmtWSuDvGX07OpOGmsoVQ44MlBfsdi22YSdpx1ggfNPOH5_NVLR2osywytTUPM0XBAagfw3ivcuY87oRrg0ez62gq5tBFRbtLqW0E9qkH_a52YZ4KC7mfaQGJSv2LtTFiaFfFdQ7heKAM=" rel="nofollow">*www.alk.net*</a>*.*

**Attachment**

-   <a href="https://www.globenewswire.com/Tracker?data=1zn6lzu_vIP1jLCdWMXkEisLPM_e0hMXM7obATdYmsFe2bZWYGY4APoMPZft9kelrjD44pjwZifMP1VtUJ5CKTBp9Jd9A9TnQUkf3WUqh3y4pSI_pVVWlq3PiaeVUztAdjirw9gdA5JyRVKo6clj6cpBokfynn-UWhYZ8hLc8_wxXx4jzYaPP-beOeAPuQF72naIlfrqGdutzRjlf0mATT0_4UgheB7-0800EIDcI2Q=" rel="nofollow">InvestorNews\_16November26\_Jefferies Global Healthcare Coference</a>

  
![](https://ml-eu.globenewswire.com/media/YzE1MDI3ZjktYWQ5My00NTE3LWEyMzEtNTkwZmMwZDMwMGFlLTEwMTM4MDQtMjAyNi0xMS0xNi1lbg==/tiny/ALK-Abello.png)

## Related

- [OptimizeRx to Participate in the 15th Annual ROTH Technology Conference](https://healthcarenews.io/news/optimizerx-to-participate-in-the-15th-annual-roth-technology-conference.md)
- [Clearmind Achieves Full Enrollment for Part C in CMND-100 Phase I/IIa Trial, Marking Key Clinical Milestone](https://healthcarenews.io/news/clearmind-achieves-full-enrollment-for-part-c-in-cmnd-100-phase-i-iia-trial-marking-key-cl.md)
- [Rein Therapeutics Announces Preliminary Blinded Phase 2 RENEW Data Showing Encouraging Lung Function Trends in Patients with Idiopathic Pulmonary Fibrosis and Reports Third Quarter 2026 Financial Results](https://healthcarenews.io/news/rein-therapeutics-announces-preliminary-blinded-phase-2-renew-data-showing-encouraging-lun.md)
- [Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032](https://healthcarenews.io/news/surgery-partners-inc-announces-commencement-of-consent-solicitation-relating-to-surgery-ce.md)
